申请人:Abbott Laboratories
公开号:US05358955A1
公开(公告)日:1994-10-25
The present invention relates to a compound of the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein W is selected from optionally substituted pyridyl, naphthyl, and quinolyl; which inhibits lipoxygenase enzyme activity and leukotriene biosynthesis and is useful in the treatment of inflammatory disease states; also disclosed are leukotriene biosynthesis inhibiting compositions and a method for inhibiting lipoxygenase enzyme activity and leukotriene biosynthesis.
本发明涉及以下式的化合物##STR1##或其药学上可接受的盐,其中W选自可选择的取代吡啶基、萘基和喹啉基;该化合物抑制脂氧合酶酶活性和白三烯生物合成,在治疗炎症性疾病状态中有用;还公开了抑制白三烯生物合成的组合物和抑制脂氧合酶酶活性和白三烯生物合成的方法。